NCT04012450

Brief Summary

Women who fulfil the inclusion criteria and who intended to regional anesthesia will be randomized into the epidural anesthesia arm or to the spinal-epidural anesthesia arm. Sonographic evaluation of the flow in the uterine artery, umbilical artery, and middle cerebral artery will be documented to each patient prior and following the regional anesthesia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
23 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

July 9, 2019

Status Verified

July 1, 2019

Enrollment Period

2.1 years

First QC Date

July 5, 2019

Last Update Submit

July 5, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Uterine artery flow

    Changes in uterine artery flow before and after regional anesthesia

    Up to 48 hours from onset of anesthesia

  • Umbilical artery flow

    Changes in umbilical artery flow before and after regional anesthesia

    Up to 48 hours from onset of anesthesia

  • Middle cerebral artery flow

    Changes in middle cerebral artery flow before and after regional anesthesia

    Up to 48 hours from onset of anesthesia

Secondary Outcomes (7)

  • Fetal heart rate abnormalities

    Up to 48 hours from onset of anesthesia

  • Fetal bradycardia within 1 hour

    Up to one hour from onset of anesthesia

  • Mode of delivery

    Up to delivery

  • Meconial amniotic fluid

    Up to delivery

  • Umbilical artery blood acidity level (PH)

    Immediate after delivery

  • +2 more secondary outcomes

Study Arms (2)

Epidural Anesthesia

ACTIVE COMPARATOR

Women in labor receiving epidural anesthesia

Procedure: Epidural anesthesia

Spinal-epidural

ACTIVE COMPARATOR

Women in labor receiving spinal-epidural anesthesia

Procedure: spina-epidural anesthesia

Interventions

Performing an epidural anesthesia

Epidural Anesthesia

Performing a spina-epidural anesthesia

Spinal-epidural

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Gestational age of 37 and above Singleton Vertex presentation Desired regional anesthesia

You may not qualify if:

  • Contraindication to regional anesthesia Placental abnormalities (placenta previa, placenta accreta, placental separation) Pregnancy following fetal reduction or intrauterine fetal death (IUFD) Fetal malformations Intrauterine growth retardation (IUGR) Suspected chorioamnionitis (including body temperature above 38.5 degrees Celsius)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Anesthesia, Epidural

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Saar Aharoni, MD

    Rambam Heath-Care Campus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 5, 2019

First Posted

July 9, 2019

Study Start

August 1, 2019

Primary Completion

August 31, 2021

Study Completion

April 1, 2022

Last Updated

July 9, 2019

Record last verified: 2019-07